Overview Dividends

(WELL) Welltower - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US95040Q1040

Seniors Housing, Outpatient Medical, Wellness Communities

WELL EPS (Earnings per Share)

EPS Growth (3Y CAGR): 198.65%
EPS Trend (3Y Correlation): 82.0%

WELL Revenue

Revenue Growth (3Y CAGR): 23.31%
Revenue Trend (3Y Correlation): 97.7%

Description: WELL Welltower September 25, 2025

Welltower Inc. (NYSE: WELL) is an S&P 500-listed REIT that owns and operates more than 1,500 senior-focused housing and wellness communities, plus outpatient medical office buildings, across the United States, United Kingdom, and Canada. The company positions these assets at the nexus of housing, health care, and hospitality, emphasizing “vibrant” environments for mature renters and supporting physicians with purpose-built infrastructure.

Recent performance metrics (as of Q3 2024) show an aggregate occupancy rate of roughly 94 % for its senior housing portfolio and a year-over-year FFO (Funds From Operations) growth of 7.5 %, driven largely by rent escalations tied to inflation-linked leases. The balance sheet remains solid, with a net debt-to-EBITDA ratio of 5.2×, but the REIT’s cost of capital is sensitive to prevailing interest-rate trends.

Key macro drivers include the aging of the U.S. baby-boom cohort, which is projected to add ~10 million adults aged 65+ by 2030, and a sustained shift toward outpatient care that fuels demand for Welltower’s medical office assets. However, the sector’s growth is contingent on the trajectory of inflation and monetary policy, as higher rates can compress cap rates and increase financing costs for new developments.

For a data-driven deep-dive into Welltower’s valuation assumptions and scenario analysis, consider exploring the analyst tools on ValueRay.

WELL Stock Overview

Market Cap in USD	124,253m
Sub-Industry	Health Care REITs
IPO / Inception	2001-01-02

WELL Stock Ratings

Growth Rating	94.3%
Fundamental	60.8%
Dividend Rating	46.9%
Return 12m vs S&P 500	24.6%
Analyst Rating	4.30 of 5

WELL Dividends

Dividend Yield 12m	1.46%
Yield on Cost 5y	4.70%
Annual Growth 5y	-1.32%
Payout Consistency	97.5%
Payout Ratio	1.6%

WELL Growth Ratios

Growth Correlation 3m	83.8%
Growth Correlation 12m	93.8%
Growth Correlation 5y	84.8%
CAGR 5y	42.95%
CAGR/Max DD 3y (Calmar Ratio)	2.85
CAGR/Mean DD 3y (Pain Ratio)	15.48
Sharpe Ratio 12m	2.65
Alpha	24.65
Beta	0.911
Volatility	19.73%
Current Volume	3826.9k
Average Volume 20d	2862.5k
Stop Loss	182.1 (-3%)
Signal	0.33

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (958.0m TTM) > 0 and > 6% of Revenue (6% = 588.6m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.81pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 91.01% (prev 73.19%; Δ 17.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.05 (>3.0%) and CFO 2.79b > Net Income 958.0m (YES >=105%, WARN >=100%)

Net Debt (11.36b) to EBITDA (3.34b) ratio: 3.40 <= 3.0 (WARN <= 3.5)

Current Ratio 5.40 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (685.4m) change vs 12m ago 10.85% (target <= -2.0% for YES)

Gross Margin 39.21% (prev 39.38%; Δ -0.17pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 18.09% (prev 15.02%; Δ 3.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 2.22 (EBITDA TTM 3.34b / Interest Expense TTM 602.6m) >= 6 (WARN >= 3)

Altman Z'' 0.25

(A) 0.15 = (Total Current Assets 10.96b - Total Current Liabilities 2.03b) / Total Assets 59.50b

(B) -0.15 = Retained Earnings (Balance) -8.75b / Total Assets 59.50b

(D) -0.40 = Book Value of Equity -8.28b / Total Liabilities 20.48b

Total Rating: 0.25 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.79

1. Piotroski 3.0pt = -2.0

2. FCF Yield 2.04% = 1.02

3. FCF Margin 28.26% = 7.07

4. Debt/Equity 0.47 = 2.39

5. Debt/Ebitda 3.40 = -2.23

6. ROIC - WACC (= -5.70)% = -7.13

7. RoE 2.73% = 0.23

8. Rev. Trend 97.74% = 7.33

9. EPS Trend 82.04% = 4.10

What is the price of WELL shares?

As of November 07, 2025, the stock is trading at USD 187.76 with a total of 3,826,900 shares traded.
Over the past week, the price has changed by +3.80%, over one month by +7.82%, over three months by +11.62% and over the past year by +43.08%.

Is Welltower a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Welltower is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 60.79 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WELL is around 233.77 USD . This means that WELL is currently undervalued and has a potential upside of +24.5% (Margin of Safety).

Is WELL a buy, sell or hold?

Welltower has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy WELL.

Strong Buy: 10
Buy: 6
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the WELL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	191.5	2%
Analysts Target Price	191.5	2%
ValueRay Target Price	260.1	38.5%

WELL Fundamental Data Overview November 01, 2025

Market Cap USD = 124.25b (124.25b USD * 1.0 USD.USD)
P/E Trailing = 124.8552
P/E Forward = 68.0272
P/S = 12.5408
P/B = 3.2696
P/EG = 3.6218
Beta = 0.911
Revenue TTM = 9.81b USD
EBIT TTM = 1.34b USD
EBITDA TTM = 3.34b USD
Long Term Debt = 15.50b USD (from longTermDebt, last fiscal year)
Short Term Debt = 62.7m USD (from shortTermDebt, two quarters ago)
Debt = 18.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.36b USD (from netDebt column, last quarter)
Enterprise Value = 135.61b USD (124.25b + Debt 18.16b - CCE 6.81b)
Interest Coverage Ratio = 2.22 (Ebit TTM 1.34b / Interest Expense TTM 602.6m)
FCF Yield = 2.04% (FCF TTM 2.77b / Enterprise Value 135.61b)
FCF Margin = 28.26% (FCF TTM 2.77b / Revenue TTM 9.81b)
Net Margin = 9.77% (Net Income TTM 958.0m / Revenue TTM 9.81b)
Gross Margin = 39.21% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.96b) / Revenue TTM)
Gross Margin QoQ = 41.28% (prev 39.80%)
Tobins Q-Ratio = 2.28 (Enterprise Value 135.61b / Total Assets 59.50b)
Interest Expense / Debt = 0.89% (Interest Expense 162.1m / Debt 18.16b)
Taxrate = 4.28% (12.5m / 293.1m)
NOPAT = 1.28b (EBIT 1.34b * (1 - 4.28%))
Current Ratio = 5.40 (Total Current Assets 10.96b / Total Current Liabilities 2.03b)
Debt / Equity = 0.47 (Debt 18.16b / totalStockholderEquity, last quarter 38.76b)
Debt / EBITDA = 3.40 (Net Debt 11.36b / EBITDA 3.34b)
Debt / FCF = 4.10 (Net Debt 11.36b / FCF TTM 2.77b)
Total Stockholder Equity = 35.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.61% (Net Income 958.0m / Total Assets 59.50b)
RoE = 2.73% (Net Income TTM 958.0m / Total Stockholder Equity 35.14b)
RoCE = 2.65% (EBIT 1.34b / Capital Employed (Equity 35.14b + L.T.Debt 15.50b))
RoIC = 2.58% (NOPAT 1.28b / Invested Capital 49.67b)
WACC = 8.28% (E(124.25b)/V(142.42b) * Re(9.37%) + D(18.16b)/V(142.42b) * Rd(0.89%) * (1-Tc(0.04)))
Discount Rate = 9.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.39%
[DCF Debug] Terminal Value 76.71% ; FCFE base≈2.42b ; Y1≈2.88b ; Y5≈4.55b
Fair Price DCF = 89.32 (DCF Value 61.30b / Shares Outstanding 686.3m; 5y FCF grow 20.56% → 3.0% )
EPS Correlation: 82.04 | EPS CAGR: 198.6% | SUE: 0.17 | # QB: 0
Revenue Correlation: 97.74 | Revenue CAGR: 23.31% | SUE: -0.41 | # QB: 0

Additional Sources for WELL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle